Clinical Trials Directory

Trials / Completed

CompletedNCT04423978

Implications of Covid-19 on the Lifestyle Changes

Implications of Covid-19 on the Lifestyle Changes and Supports Used (ICOLS): a Survey in the Province of Reggio Emilia

Status
Completed
Phase
Study type
Observational
Enrollment
1,826 (actual)
Sponsor
Azienda USL Reggio Emilia - IRCCS · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Northern Italy has been profoundly touched by the Covid-19 pandemic. To limit the outbreaks of contagion, the Italian government imposed 2.months of complete lock-down, which imposed the social isolation for the whole population and, for those positive to the Covid-19, the complete confinement at home. Despite the recommendations for conserving healthy lifestyle of the Italian Government, during the lock-down the likelihood to fall into unhealthy behaviours might have increased. This study aims to describe the impact of Covid-19 on the lifestyles of a population of Italian adults living in an area of high spread of Sars-CoV-2.

Detailed description

The aims of this study were to detect the changes in lifestyles occurred during the imposed lock-down phase and the support services used the most by participants. This study consists in the administration of an on-line survey addressed to adult individuals living in the province of Reggio Emilia (Italy). The survey was posted on-line on the website of the Azienda USL- IRCCS di Reggio Emilia and it was spread to the community through apps and social networks. The on-line survey is free to access, self-administered and it consists of 50 questions. The questions investigates the changes occurred in employment status, physical exercise, diet, tobacco and alcohol consumption, sleep quality and leisure activities during the pandemic lock-down phase as well as the available local support services used and perceived as useful.

Conditions

Timeline

Start date
2020-05-04
Primary completion
2020-06-15
Completion
2020-06-15
First posted
2020-06-09
Last updated
2025-06-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04423978. Inclusion in this directory is not an endorsement.